| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.3 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |